Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Vericel Reaffirms Full-year 2025 Profitability Guidance Of Gross Margin Of 74% And Adjusted EBITDA Margin Of 26%

Author: Benzinga Newsdesk | July 31, 2025 07:11am

2025 Financial Guidance

Reaffirmed MACI full-year revenue growth in the low 20% range
Updated Burn Care revenue guidance for the second half of 2025 to be in line with recent run rate of approximately $10 million per quarter
Reaffirmed full-year profitability guidance of gross margin of 74% and adjusted EBITDA margin of 26%

Posted In: VCEL